Deutsche Bank’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
+19,361
| New | +$217K | ﹤0.01% | 2910 |
|
|
2020
Q2 | – | Sell |
-233
| Closed | -$8K | – | 4303 |
|
|
2020
Q1 | $8K | Buy |
233
+48
| +26% | +$1.65K | ﹤0.01% | 3953 |
|
|
2019
Q4 | $12K | Buy |
+185
| New | +$12K | ﹤0.01% | 4250 |
|
|
2018
Q2 | – | Sell |
-1,630
| Closed | -$175K | – | 5036 |
|
|
2018
Q1 | $175K | Buy |
1,630
+1,606
| +6,692% | +$172K | ﹤0.01% | 4121 |
|
|
2017
Q4 | $6K | Sell |
24
-386
| -94% | -$96.5K | ﹤0.01% | 4342 |
|
|
2017
Q3 | $101K | Buy |
410
+131
| +47% | +$32.3K | ﹤0.01% | 3967 |
|
|
2017
Q2 | $144K | Buy |
279
+65
| +30% | +$33.5K | ﹤0.01% | 3901 |
|
|
2017
Q1 | $117K | Buy |
214
+1
| +0.5% | +$547 | ﹤0.01% | 3661 |
|
|
2016
Q4 | $131K | Buy |
213
+38
| +22% | +$23.4K | ﹤0.01% | 3748 |
|
|
2016
Q3 | $106K | Hold |
175
| – | – | ﹤0.01% | 3725 |
|
|
2016
Q2 | $109K | Hold |
175
| – | – | ﹤0.01% | 3896 |
|
|
2016
Q1 | $130K | Hold |
175
| – | – | ﹤0.01% | 3712 |
|
|
2015
Q4 | $175K | Buy |
175
+59
| +51% | +$59K | ﹤0.01% | 3628 |
|
|
2015
Q3 | $124K | Buy |
116
+103
| +792% | +$110K | ﹤0.01% | 3826 |
|
|
2015
Q2 | $23K | Buy |
+13
| New | +$23K | ﹤0.01% | 4468 |
|
|
2014
Q1 | – | Sell |
-232
| Closed | -$589K | – | 5218 |
|
|
2013
Q4 | $589K | Buy |
232
+180
| +346% | +$457K | ﹤0.01% | 2987 |
|
|
2013
Q3 | $125K | Buy |
52
+44
| +550% | +$106K | ﹤0.01% | 4324 |
|
|
2013
Q2 | $16K | Buy |
+8
| New | +$16K | ﹤0.01% | 4722 |
|